Kenji Amemiya

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Endometrial Cancer

Top Venues

Journal of gynecologic oncology

Cancer cytopathology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer. Journal of gynecologic oncology 35 (4) (2024)
Kenji Amemiya, Yosuke Hirotsu, Yuki Nagakubo, Hitoshi Mochizuki, Toshio Oyama, Masao Omata
Influence of formalin fixation duration on RNA quality and quantity from formalin-fixed paraffin-embedded hepatocellular carcinoma tissues. Pathology international (2023)
Kei Kunimasa, Yosuke Hirotsu, Kenji Amemiya, Keiichiro Honma, Harumi Nakamura, Kazumi Nishino, Masao Omata
Genetic dissection of intratumor heterogeneity of PD-L1 expression in EGFR-mutated lung adenocarcinoma. Thoracic cancer (2023)
Kenichiro Okimoto, Yosuke Hirotsu, Makoto Arai, Kenji Amemiya, Naoki Akizue, Yuki Ohta, Takashi Taida, Keiko Saito, Hiroshi Ohyama, Tomoaki Matsumura, Motoi Nishimura, Kazuyuki Matsushita, Keisuke Matsusaka, Toshio Oyama, Hitoshi Mochizuki, Tetsuhiro Chiba, Jun Kato, Jun-Ichiro Ikeda, Osamu Yokosuka, Naoya Kato, Masao Omata
Validity of pathological diagnosis for early colorectal cancer in genetic background. Cancer medicine (2023)
Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Rumi Higuchi, Takahiro Nakagomi, Taichiro Goto, Toshio Oyama, Tetsuo Kondo, Masao Omata
Deep targeted sequencing of cytological tumor cells using whole genome amplification. Cancer cytopathology (2022)
Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Molecular analysis of ascitic fluid cytology reflects genetic changes of malignancies of the ovary equivalent to surgically resected specimens. Cancer cytopathology 130 (8) (2022)
Kenji Amemiya, Yosuke Hirotsu, Yuki Nagakubo, Shunsuke Watanabe, Saki Amemiya, Hitoshi Mochizuki, Toshio Oyama, Tetsuo Kondo, Masao Omata
Simple IHC reveals complex MMR alternations than PCR assays: Validation by LCM and next-generation sequencing. Cancer medicine (2022)
Ikuko Sakamoto, Yosuke Hirotsu, Kenji Amemiya, Takahiro Nozaki, Hitoshi Mochizuki, Masao Omata
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis. Journal of gynecologic oncology (2022)
Sotaro Otake, Taichiro Goto, Rumi Higuchi, Takahiro Nakagomi, Yosuke Hirotsu, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki, Masao Omata
The Diagnostic Utility of Cell-Free DNA from Ex Vivo Bronchoalveolar Lavage Fluid in Lung Cancer. Cancers 14 (7) (2022)
Kenji Amemiya, Yosuke Hirotsu, Yuki Nagakubo, Hitoshi Mochizuki, Rumi Higuchi, Toshiharu Tsutsui, Yumiko Kakizaki, Yoshihiro Miyashita, Toshio Oyama, Masao Omata
Actionable driver DNA variants and fusion genes can be detected in archived cytological specimens with the Oncomine Dx Target Test Multi-CDx system in lung cancer. Cancer cytopathology 129 (9) (2021)